Mon, 27-Jun-2022

Chronic Diseases

Gelesis Receives Approval to Market PLENITY in Europ...

Gelesis, a biotechnology company developing a novel hydrogel platform technology to treat obesity and other chronic diseases related to the gastrointestinal (GI) tract, announced today that it has received app... June 2, 2020 8:14 am By Neha Mule

Rising Prevalence of COVID-19 and Chronic Diseases C...

In many countries, the number of COVID-19 patients has exceeded the number of beds available in hospitals. This has become a common scenario due to the exponential increase in the number of patients caused by ... May 25, 2020 2:22 pm By Neha Mule

Related News